Antibody–Drug Conjugates (ADCs): Leading the Global Oncology RevolutionAs cancer treatment enters the era of precision and personalization, Antibody–Drug Conjugates (ADCs)—often referred to as “biological missiles”—represent one of the highest frontiers of ...Learn More

China’s innovative drug sector has notched another record-breaking milestone as Innovent Biologics announced a partnership worth up to $11.4 billion with Takeda Pharmaceutical.According to the agreement, Innovent will receive a $1.2 billion upfront payment, including a $100 ...Learn More

Berlin, Germany — The annual European Society for Medical Oncology (ESMO) Congress, held from October 17–21, became a stage for China’s rapid ascent in pharmaceutical innovation. This year, Chinese biotech companies achieved record participation, with 35 studies accepted for ...Learn More

I've spent a good part of my career working with vascular biology models, and one trend that's been hard to ignore lately is the rise of non-human primate (NHP) microvascular endothelial cells (MVECs). These tiny but mighty cells are starting to take center stage in labs ...Learn More

Creative Biolabs reveals the development methodologies for bispecifics for specific targeting purposes.The global biopharmaceutical industry is buzzing over the next wave of immunotherapy breakthroughs, and bispecific antibodies (bsAbs) are among them to have a serious moment in ...Learn More